Fundz

Denali Therapeutics reported raising $500 Million in an initial SEC Form D filing, from an offering of $500 Million

PUBLIC · DNLIMar 01, 2024

Amount Raised

$500 Million

$500 Million sold, per SEC Form D (first sale Feb 29, 2024)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

Denali Therapeutics raised $500 Million in a funding round, dated February 29, 2024. Denali Therapeutics is based in South San Francisco, California, United States.

How much did Denali Therapeutics raise?
Denali Therapeutics raised $500 Million in a funding round on February 29, 2024.
What does Denali Therapeutics do?
Denali Therapeutics is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using its proprietary TransportVehicle™ platform.
Where is Denali Therapeutics based and how big is it?
Denali Therapeutics is based in South San Francisco, California, United States. Fundz records about 567 employees.
Who are the decision-makers at Denali Therapeutics?
Fundz holds 1 contact at Denali Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Denali Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
  • BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
  • TORL BioTherapeutics raised $158M on April 4, 2024.
  • AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
  • Adipo Therapeutics raised $1.9M (Seed) on March 7, 2024.
  • Parabilis Medicines raised $145M (Series E) on March 1, 2024.

Who to call at Denali Therapeutics, and when

A new round usually means Denali Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Denali Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Denali Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Denali Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Denali Therapeutics

Location

161 OYSTER POINT BLVD.

South San Francisco, California, United States

About

Denali Therapeutics is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using its proprietary TransportVehicle™ platform. With a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, Denali Therapeutics is advancing toward its goal of delivering effective medicines to transform the lives of people living with neurodegenerative, lysosomal storage and other serious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Denali Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Denali Therapeutics's next move

See what Strategic adds

Denali Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.